Medline Inc. income statement

In fiscal 2025, Medline Inc. reported revenue of $28.43bn, up 11.5% on the year before, operating income of $2.21bn (a 7.8% margin) and net income of $1.15bn, or −$0.01 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ billions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Medline Inc.: income statement, annual
Fiscal year	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Revenue	21.4	23.2	25.5	28.4
Cost of revenue	—	17.3	18.5	20.9
Gross profit	5.2	5.9	7.0	7.5
Research and development	—	0.1	0.1	0.1
Selling, general and administrative	—	3.9	4.1	4.5
Operating income	0.9	1.3	2.1	2.2
Interest expense	—	1.2	1.1	0.9
Income before tax	—	0.3	1.2	1.2
Income tax	—	0.0	0.0	0.1
Net income	−0.0	0.2	1.2	1.2
Diluted EPS	—	—	—	−$0.01
Diluted shares (average)	—	—	—	810m
EBITDA	—	2.2	3.1	3.2

US$ millions unless shown otherwise. Fiscal quarters.

Medline Inc.: income statement, quarterly
Quarter	2024 Q3Sept 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Revenue	6,388	6,644	6,886	7,115	7,352	7,685
Cost of revenue	—	4,820	4,981	—	5,511	5,470
Gross profit	1,757	1,824	1,905	1,875	1,841	2,215
Selling, general and administrative	—	1,070	1,073	—	1,228	1,295
Operating income	574	571	642	574	422	395
Interest expense	—	244	253	—	165	168
Income before tax	—	338	359	—	291	235
Income tax	—	16	26	—	52	96
Net income	324	319	329	322	132	59
Diluted EPS	—	—	—	—	$0.16	$0.07
EBITDA	—	818	892	—	676	651

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: HSIC vs MDLN COR vs MDLN MCK vs MDLN

More: Health Care Distributors stocks compared, Health Care sector, rankings of US companies

Figures from Medline Inc.'s SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Medline Inc.